Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04874636 · ClinicalTrials.gov registry record · Phase 2

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain

A Phase 2 study of Chronic Low Back Pain, sponsored by Eli Lilly and Company.

Completed
Registry status
Phase 2
Development phase
153
Enrollment target
20
Study locations

NCT04874636 is a Phase 2 study of Chronic Low Back Pain that has completed, run by Eli Lilly and Company. The registered enrollment target is 153 participants, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (74% lower). The trial reports 20 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04874636, a Phase 2 study of Chronic Low Back Pain, has completed, sponsored by Eli Lilly and Company.

COMPLETED
Registry status
Phase 2
Development phase
153 participants
Enrollment target
20
Study locations

Study Summary

This study is being done to test the safety and efficacy of the study drug LY3556050 for the treatment of chronic low back pain. This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

Conditions Studied

Chronic Low Back Pain

Interventions

  • DRUG Placebo
  • DRUG LY3556050

Study Locations (20)

Florida

  • VIN-Julie Schwartzbard - Aventura
  • Clinical Research of South Florida - Coral Gables
  • Suncoast Research Group - Miami
  • University of Miami Don Suffer Clinical Research Building - Miami
  • New Horizon Research Center - Miami
  • Renstar Medical Research - Ocala
  • Synexus Clinical Research US, Inc - Orlando - Orlando
  • Synexus Clinical Research - St. Petersburg - Pinellas Park
  • Martin E. Hale M.D., P.A. - Plantation
  • Synexus Clinical Research US, Inc - Orlando - The Villages

Arizona

  • Synexus- Chandler - Chandler
  • Synexus Clinical Research - Glendale - Glendale
  • Alliance for Multispecialty Research - Clinical Research Consortium - Tempe

California

  • Irvine Clinical Research Center - Irvine
  • Artemis Institute for Clinical Research - Riverside
  • Artemis Institute for Clinical Research - San Diego

Illinois

  • Synexus Clinical Research - Chicago
  • Northwestern University - Chicago

Alabama

  • Simon Williamson Clinic - Birmingham

Connecticut

  • CMR of Greater New Haven - Hamden

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2021-05-20
Est. Completion 2022-02-09
Phase Phase 2

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04874636

The ClinicalTrials.gov registry entry for NCT04874636 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 590-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (74% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04874636 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT04874636 about?

NCT04874636 is a clinical study titled "Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Chronic Low Back Pain". This study is being done to test the safety and efficacy of the study drug LY3556050 for the treatment of chronic low back pain. This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

What is the current status of trial NCT04874636?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 153 participants. The study started on 2021-05-20. Estimated completion is 2022-02-09.

What conditions does trial NCT04874636 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT04874636?

The interventions under investigation include: Placebo (DRUG), LY3556050 (DRUG).

Who is sponsoring clinical trial NCT04874636?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04874636 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Low Back Pain

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.